News
Morning Overview on MSN1d
The first AI-generated drug enters clinical trials
The world of medicine has taken a significant leap forward with the first AI-generated drug entering clinical trials. This breakthrough has the potential to revolutionize drug discovery, transforming ...
On Tuesday, life sciences company LabCorp announced a new technology platform to help streamline the clinical trial and drug development process. The platform was designed for LabCorp’s drug ...
LabCorp Transforms the Clinical Trial Experience And Streamlines the Drug Development Process Advancements in Technology and Patient Access Deliver Better Clinical Trial Access, Quality, and ...
With a commitment to process optimization, training, and audits to enhance their operations, CROs can ensure the integrity of medications throughout the trial process.
Conclusion Because of their complexity, the overall development time for phase III clinical trials is lengthy, process laden, and highly variable. To streamline the process, a solution must be sought ...
In this Q&A from the 2025 Veeva R&D and Quality Summit, Ibrahim Kamstrup-Akkaoui, vice president of data systems innovation at Novo Nordisk, discusses simplifying system use through the company’s ...
LOWELL, Mass. – Biotech and medical-device entrepreneurs preparing to test their innovations in clinical trials will gain insights into that process during free programs presented by the Massachusetts ...
With the emergence of smart and connected devices and technologies, CROs and life sciences organizations are able to more easily perform decentralized, virtual clinical trials. Now, industry ...
Learn more about therapeutic synthesis pathways. Drug development is a process that spans many years, from the initial phase of identifying potential drug candidates to testing for safety and efficacy ...
Makary announced plans for a new rare disease pathway in an April episode of "The Megyn Kelly Show." The proposal follows ...
A new tech startup wants to disrupt the clinical trial process and landed $203 million to help scale up its technology. Paradigm, a clinical trials data and patient-matching platform, aims to open ...
Victorian brain cancer researchers have achieved a global-first, using an innovative process to learn how a new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results